HOME › DRUGS › BUDESONIDE;FORMOTEROL FUMARATE DIHYDRATE
ACTIVE SUBSTANCE / INN

BUDESONIDE;FORMOTEROL FUMARATE DIHYDRATE

Brand name(s): GoResp Digihaler (previously Budesonide/Formoterol Teva Pharma B.V.), Budesonide/Formoterol Teva Pharma B.V.
EMA LISTED
WITHDRAWN
AUTHORISED
Asthma;Pulmonary Disease, Chronic Obstructive
Asthma
ACTIVE SUBSTANCE
Budesonide;Formoterol Fumarate Dihydrate
REGULATORS
EMA
SPONSORS / MAH
Teva Pharma B.V. , Teva Pharma B.V.
TOTAL APPLICATIONS
2
EMA AUTHORISATIONS
PRODUCT NAMEHOLDERSTATUSDATEINDICATION
GoResp Digihaler (previously Budesonide/Formoterol Teva Pharma B.V.)Teva Pharma B.V. Authorised03/04/2020Asthma;Pulmonary Disease, Chronic Obstructive
Budesonide/Formoterol Teva Pharma B.V.Teva Pharma B.V.Withdrawn19/11/2014Asthma

FULL INTELLIGENCE ON BUDESONIDE;FORMOTEROL FUMARATE DIHYDRATE

Patent cliffs, clinical trials, pipeline data, AI-enriched regulatory signals — free on PharmaSignal.

OPEN PLATFORM →